Pharmaceutical Study of Aconitum Heterophyllum (Ativisha)Shodhana and Analysis Based on Hptlc and Hplc
International Research Journal of Ayurveda and Yoga · 24.07.2026 · 9 (4) · 36-40
DOI: 10.48165/irjay.2026.9.04.06 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Research Journal of Ayurveda and Yoga, online erschienen am 24.07.2026. Verfasst von Kritika Verma und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ativisha (Aconitum heterophyllum), a prominent drug in the Ranunculaceae family, is extensively cited in the Charaka and Sushruta Samhitas for its therapeutic efficacy. However, its potent diterpene alkaloids necessitate "Shodhana" (systematic purification) to ensure clinical safety and enhance pharmacological action. This review examines classical Shodhana protocols and their impact on the plant's chemical profile, specifically evaluating how these traditional processes mitigate toxicity. This work highlights the importance of classical Shodhana process in optimizing the bioavailability of phytochemical metabolites and impact on the plant's chemical profile ensuring the safety of herbal interventions in primary healthcare.
Zitieren
APA
Verma, K., & Arya, N. (2026). Pharmaceutical Study of Aconitum Heterophyllum (Ativisha)Shodhana and Analysis Based on Hptlc and Hplc. International Research Journal of Ayurveda and Yoga, 9(4), 36-40. https://doi.org/10.48165/irjay.2026.9.04.06
Vancouver
Verma K, Arya N. Pharmaceutical Study of Aconitum Heterophyllum (Ativisha)Shodhana and Analysis Based on Hptlc and Hplc. International Research Journal of Ayurveda and Yoga. 2026;9(4):36-40. doi:10.48165/irjay.2026.9.04.06
BibTeX
@article{Verma2026,
author = {Verma, Kritika and Arya, Neha},
title = {Pharmaceutical Study of Aconitum Heterophyllum (Ativisha)Shodhana and Analysis Based on Hptlc and Hplc},
journal = {International Research Journal of Ayurveda and Yoga},
year = {2026},
volume = {9},
number = {4},
pages = {36--40},
doi = {10.48165/irjay.2026.9.04.06}
}
EUVIMED